The aim of the research was to study the status of TNF-α, CRP, adiponectin, leptin and resistin as links for starting up mechanisms for the development and progression of the low-grade chronic inflammatory response in patients with CP and T2DM. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.